Literature DB >> 24878241

Functional insight into development of positive allosteric modulators of AMPA receptors.

Autumn M Weeks1, Jonathan E Harms2, Kathryn M Partin3, Morris Benveniste4.   

Abstract

Positive allosteric modulators of α-amino-3-hydroxy-5-methyl-isoxazole-propionic acid (AMPA) ionotropic glutamate receptors facilitate synaptic plasticity and contribute essentially to learning and memory, properties which make AMPA receptors targets for drug discovery and development. One region at which several different classes of positive allosteric modulators bind lies at the dimer interface between the ligand-binding core of the second, membrane-proximal, extracellular domain of AMPA receptors. This solvent-accessible binding pocket has been the target of drug discovery efforts, leading to the recent delineation of five "subsites" which differentially allow access to modulator moieties, and for which distinct modulator affinities and apparent efficacies are attributed. Here we use the voltage-clamp technique in conjunction with rapid drug application to study the effects of mutants lining subsites "A" and "B" of the allosteric modulator pocket to assess affinity and efficacy of allosteric modulation by cyclothiazide, CX614, CMPDA and CMPDB. A novel analysis of the decay of current produced by the onset of desensitization has allowed us to estimate both affinity and efficacy from single concentrations of modulator. Such an approach may be useful for effective high throughput screening of new target compounds.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  AMPAkine; Allosteric modulation; Deactivation; Desensitization; Electrophysiology; Ion channel gating; Mutagenesis; Neuropharmacology

Mesh:

Substances:

Year:  2014        PMID: 24878241      PMCID: PMC4107126          DOI: 10.1016/j.neuropharm.2014.05.022

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  41 in total

Review 1.  Glutamate receptor ion channels: structure, regulation, and function.

Authors:  Stephen F Traynelis; Lonnie P Wollmuth; Chris J McBain; Frank S Menniti; Katie M Vance; Kevin K Ogden; Kasper B Hansen; Hongjie Yuan; Scott J Myers; Ray Dingledine
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

Review 2.  Recent advances in positive allosteric modulators of the AMPA receptor.

Authors:  John A Morrow; John K F Maclean; Craig Jamieson
Journal:  Curr Opin Drug Discov Devel       Date:  2006-09

3.  Targeting AMPA receptor gating processes with allosteric modulators and mutations.

Authors:  Nicholas A Mitchell; Mark W Fleck
Journal:  Biophys J       Date:  2007-01-05       Impact factor: 4.033

4.  A novel class of AMPA receptor allosteric modulators. Part 1: design, synthesis, and SAR of 3-aryl-4-cyano-5-substituted-heteroaryl-2-carboxylic acid derivatives.

Authors:  Maria-Carmen Fernandez; Ana Castaño; Esteban Dominguez; Ana Escribano; Delu Jiang; Alma Jimenez; Eric Hong; William J Hornback; Eric S Nisenbaum; Nancy Rankl; Eric Tromiczak; Grant Vaught; Hamideh Zarrinmayeh; Dennis M Zimmerman
Journal:  Bioorg Med Chem Lett       Date:  2006-08-01       Impact factor: 2.823

5.  AMPA receptor flip/flop mutants affecting deactivation, desensitization, and modulation by cyclothiazide, aniracetam, and thiocyanate.

Authors:  K M Partin; M W Fleck; M L Mayer
Journal:  J Neurosci       Date:  1996-11-01       Impact factor: 6.167

6.  The tetrameric structure of a glutamate receptor channel.

Authors:  C Rosenmund; Y Stern-Bach; C F Stevens
Journal:  Science       Date:  1998-06-05       Impact factor: 47.728

7.  Centrally active modulators of glutamate receptors facilitate the induction of long-term potentiation in vivo.

Authors:  U Stäubli; Y Perez; F B Xu; G Rogers; M Ingvar; S Stone-Elander; G Lynch
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

8.  Mechanism of positive allosteric modulators acting on AMPA receptors.

Authors:  Rongsheng Jin; Suzanne Clark; Autumn M Weeks; Joshua T Dudman; Eric Gouaux; Kathryn M Partin
Journal:  J Neurosci       Date:  2005-09-28       Impact factor: 6.167

Review 9.  Therapeutic potential of positive AMPA modulators and their relationship to AMPA receptor subunits. A review of preclinical data.

Authors:  Mark D Black
Journal:  Psychopharmacology (Berl)       Date:  2005-01-26       Impact factor: 4.530

Review 10.  Pharmacology of ampakine modulators: from AMPA receptors to synapses and behavior.

Authors:  A C Arai; M Kessler
Journal:  Curr Drug Targets       Date:  2007-05       Impact factor: 3.465

View more
  5 in total

1.  Rational Design of a Novel AMPA Receptor Modulator through a Hybridization Approach.

Authors:  Nicola Caldwell; Jonathan E Harms; Kathryn M Partin; Craig Jamieson
Journal:  ACS Med Chem Lett       Date:  2015-02-11       Impact factor: 4.345

2.  Crystal Structures of Potent Dimeric Positive Allosteric Modulators at the Ligand-Binding Domain of the GluA2 Receptor.

Authors:  Saara Laulumaa; Kathrine Voigt Hansen; Magdalena Masternak; Thomas Drapier; Pierre Francotte; Bernard Pirotte; Karla Frydenvang; Jette Sandholm Kastrup
Journal:  ACS Med Chem Lett       Date:  2018-11-04       Impact factor: 4.345

Review 3.  AMPA receptor potentiators: from drug design to cognitive enhancement.

Authors:  Kathryn M Partin
Journal:  Curr Opin Pharmacol       Date:  2014-11-27       Impact factor: 5.547

4.  The Impact and Mechanism of a Novel Allosteric AMPA Receptor Modulator LCX001 on Protection Against Respiratory Depression in Rodents.

Authors:  Wei Dai; Xiang Gao; Dian Xiao; Yu-Lei Li; Xin-Bo Zhou; Zheng Yong; Rui-Bin Su
Journal:  Front Pharmacol       Date:  2019-02-19       Impact factor: 5.810

5.  The influence of levetiracetam in cognitive performance in healthy individuals: neuropsychological, behavioral and electrophysiological approach.

Authors:  Julio Cesar Magalhães; Mariana Gongora; Renan Vicente; Juliana Bittencourt; Guaraci Tanaka; Bruna Velasques; Silmar Teixeira; Gledys Morato; Luis F Basile; Oscar Arias-Carrión; Fernando A M S Pompeu; Mauricio Cagy; Pedro Ribeiro
Journal:  Clin Psychopharmacol Neurosci       Date:  2015-04-30       Impact factor: 2.582

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.